AXGN stock forecast
Our latest prediction for AxoGen, Inc.'s stock price was made on the Aug. 9, 2019 when the stock price was at 13.38$.
In the short term (2weeks), AXGN's stock price should outperform the market by 4.17%. During that period the price should oscillate between -7.21% and +14.95%.
In the medium term (3months), AXGN's stock price should outperform the market by 5.66%. During that period the price should oscillate between -16.89% and +35.19%.Get email alerts
About AxoGen, Inc.
AxoGen, Inc. engages in the development and market of surgical solutions for peripheral nerves. It also provide products and education to improve surgical treatment algorithms for peripheral nerve damage or discontinuity. Its products include avance nerve graft, axoguard nerve connector, axoguard nerve protector, avive soft tissue membrane, acroval neurosensory and motor testing system, and axotouch two-point discriminator. The company was founded in 1977 and is headquartered in Alachua, FL.
At the moment the company generates 96M USD in revenues.
On its last earning announcement, the company reported a loss of -0.65$ per share.
The book value per share is 3.93$
Three months stock forecastAug. 9, 2019
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|